Translatability scoring in prospective and retrospective COVID drug development cases: research
The ongoing pandemic of severe acute respiratory syndrome coronavirus 2 has led to an enormous surge of clinical research. So far, the speed and success rate of related drug development projects, especially of vaccines, is unprecedented. For the first time, this situation allowed for the opportunist...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Article (Journal) |
| Lenguaje: | inglés |
| Publicado: |
August 2023
|
| In: |
European journal of clinical pharmacology
Year: 2023, Volumen: 79, Número: 8, Pages: 1051-1071 |
| ISSN: | 1432-1041 |
| DOI: | 10.1007/s00228-023-03517-0 |
| Acceso en línea: | Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00228-023-03517-0 Verlag, kostenfrei, Volltext: https://link.springer.com/article/10.1007/s00228-023-03517-0 
|
| Notas de Autor: | Alexandra Wendler, Martin Wehling |
| Sumario: | The ongoing pandemic of severe acute respiratory syndrome coronavirus 2 has led to an enormous surge of clinical research. So far, the speed and success rate of related drug development projects, especially of vaccines, is unprecedented. For the first time, this situation allowed for the opportunistic evaluation of a translatability score, originally proposed in 2009, in a prospective manner. |
|---|---|
| Notas: | Online veröffentlicht: 6. Juni 2023 Gesehen am 04.04.2024 |
| Descripción Física: | Online Resource |
| ISSN: | 1432-1041 |
| DOI: | 10.1007/s00228-023-03517-0 |